Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 397

1.

Reliability and Validity of the Children's Depression Inventory Japanese Version.

Ozono S, Nagamitsu SI, Matsuishi T, Yamashita Y, Ogata A, Suzuki SI, Mashida N, Koseki S, Sato H, Ishikawa SI, Togasaki Y, Sato Y, Sato S, Sasaki K, Shimada H, Yamawaki S.

Pediatr Int. 2019 Jul 25. doi: 10.1111/ped.13984. [Epub ahead of print]

PMID:
31344290
2.

Clinical significance of programmed death-1 and programmed death-ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma.

Mikami S, Mizuno R, Kondo T, Shinohara N, Nonomura N, Ozono S, Eto M, Tatsugami K, Takayama T, Matsuyama H, Kishida T, Oya M; Japanese Society of Renal Cancer.

Cancer Sci. 2019 Jun;110(6):1820-1828. doi: 10.1111/cas.14019. Epub 2019 May 13.

3.

CRISPR-mediated activation of endogenous BST-2/tetherin expression inhibits wild-type HIV-1 production.

Zhang Y, Ozono S, Yao W, Tobiume M, Yamaoka S, Kishigami S, Fujita H, Tokunaga K.

Sci Rep. 2019 Feb 28;9(1):3134. doi: 10.1038/s41598-019-40003-z.

4.

Relative importance of initial conditions on outflows from multiple fans.

Takamure K, Ozono S.

Phys Rev E. 2019 Jan;99(1-1):013112. doi: 10.1103/PhysRevE.99.013112.

PMID:
30780221
5.

Membrane-associated RING-CH (MARCH) 1 and 2 are MARCH family members that inhibit HIV-1 infection.

Zhang Y, Tada T, Ozono S, Yao W, Tanaka M, Yamaoka S, Kishigami S, Fujita H, Tokunaga K.

J Biol Chem. 2019 Mar 8;294(10):3397-3405. doi: 10.1074/jbc.AC118.005907. Epub 2019 Jan 10.

PMID:
30630952
6.

Correction to: Current situation of cancer among adolescents and young adults in Japan.

Ohara A, Furui T, Shimizu C, Ozono S, Yamamoto K, Kawai A, Tatara R, Higuchi A, Horibe K.

Int J Clin Oncol. 2018 Dec;23(6):1212-1216. doi: 10.1007/s10147-018-1342-z.

PMID:
30324312
7.

A large retroperitoneal lipoblastoma: A case report and literature review.

Sakamoto S, Hashizume N, Fukahori S, Ishii S, Saikusa N, Yoshida M, Masui D, Higashidate N, Tsuruhisa S, Ozono S, Tanigawa M, Naito Y, Tanaka Y, Yagi M.

Medicine (Baltimore). 2018 Oct;97(40):e12711. doi: 10.1097/MD.0000000000012711. Review.

8.

Clinical Outcomes in Patients With Metastatic Papillary Renal-Cell Carcinoma: A Multi-Institutional Study in Japan.

Ito K, Mikami S, Tatsugami K, Masumori N, Shinohara N, Kondo T, Nakanishi S, Nagashima Y, Eto M, Kamba T, Kuroda N, Tomita Y, Matsuyama H, Onishi T, Tsushima T, Nakazawa H, Oya M, Ozono S, Naito S, Asano T.

Clin Genitourin Cancer. 2018 Dec;16(6):e1201-e1214. doi: 10.1016/j.clgc.2018.07.028. Epub 2018 Aug 11.

PMID:
30224330
9.

NCCN Asia Consensus Statement prostate cancer.

Hinotsu S, Namiki M, Ozono S, Akaza H.

Jpn J Clin Oncol. 2018 Nov 1;48(11):964-965. doi: 10.1093/jjco/hyy116. Review.

PMID:
30184146
10.

Current situation of cancer among adolescents and young adults in Japan.

Ohara A, Furui T, Shimizu C, Ozono S, Yamamoto K, Kawai A, Tatara R, Higuchi A, Horibe K.

Int J Clin Oncol. 2018 Dec;23(6):1201-1211. doi: 10.1007/s10147-018-1323-2. Epub 2018 Jul 30. Erratum in: Int J Clin Oncol. 2018 Oct 15;:.

PMID:
30062493
11.

[Current Status of Oncofertility in Adolescent and Young Adult (AYA) Generation Cancer Patients in Japan - National Survey of Oncologists].

Furui T, Takai Y, Kimura F, Kitajima M, Nakatsuka M, Morishige K, Yamamoto K, Hashimoto H, Matsumoto K, Ozono S, Horibe K, Suzuki N.

Gan To Kagaku Ryoho. 2018 May;45(5):841-846. Japanese.

PMID:
30026448
12.

Oral 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A multicenter phase III study.

Nakai Y, Inoue K, Tsuzuki T, Shimamoto T, Shuin T, Nagao K, Matsuyama H, Oyama M, Furuse H, Ozono S, Miyake M, Fujimoto K.

Int J Urol. 2018 Aug;25(8):723-729. doi: 10.1111/iju.13718. Epub 2018 Jul 12.

13.

Clinical evaluation of two consecutive UroVysion fluorescence in situ hybridization tests to detect intravesical recurrence of bladder cancer: a prospective blinded comparative study in Japan.

Kojima T, Nishiyama H, Ozono S, Hinotsu S, Keino N, Yamaguchi A, Sakai H, Enomoto Y, Horie S, Fujimoto K, Matsuyama H, Okamura T, Kanimoto Y, Oya M, Nonomura N, Naito S, Akaza H.

Int J Clin Oncol. 2018 Dec;23(6):1140-1147. doi: 10.1007/s10147-018-1311-6. Epub 2018 Jul 3.

PMID:
29971622
14.

Efficacy and safety of 3-month dosing regimen of degarelix in Japanese subjects with prostate cancer: A phase III study.

Ozono S, Tsukamoto T, Naito S, Horie S, Ohashi Y, Uemura H, Yokomizo Y, Fukasawa S, Kusuoka H, Akazawa R, Saito M, Akaza H.

Cancer Sci. 2018 Jun;109(6):1920-1929. doi: 10.1111/cas.13600. Epub 2018 May 23.

15.

Isosamidin, an extract of Peucedanum japonicum, inhibits phenylephrine-mediated contractions of the human prostate in vitro.

Suzuki T, Otsuka A, Ito Y, Yamada S, Miyake H, Ozono S.

Phytother Res. 2018 May;32(5):949-952. doi: 10.1002/ptr.6039. Epub 2018 Feb 1.

PMID:
29388272
16.

[II .Problems of Treatment for Non-Muscle Invasive Bladder Cancer].

Ozono S, Furuse H.

Gan To Kagaku Ryoho. 2018 Jan;45(1):30-32. Japanese. No abstract available.

PMID:
29362303
17.
18.

A child with anorexia nervosa presenting with severe infection with cytopenia and hemophagocytosis: a case report.

Suda M, Nagamitsu S, Kinosita M, Matsuoka M, Ozono S, Otsu Y, Yamashita Y, Matsuishi T.

Biopsychosoc Med. 2017 Sep 5;11:24. doi: 10.1186/s13030-017-0108-6. eCollection 2017.

19.

Report of the Second Asian Prostate Cancer (A-CaP) Study Meeting.

Kim CS, Lee JY, Chung BH, Kim WJ, Fai NC, Hakim L, Umbas R, Ong TA, Lim J, Letran JL, Chiong E, Wu TL, Lojanapiwat B, Türkeri L, Murphy DG, Gardiner RA, Moretti K, Cooperberg M, Carroll P, Mun SK, Hinotsu S, Hirao Y, Ozono S, Horie S, Onozawa M, Kitagawa Y, Kitamura T, Namiki M, Akaza H.

Prostate Int. 2017 Sep;5(3):95-103. doi: 10.1016/j.prnil.2017.03.006. Epub 2017 Mar 29.

20.

Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup analysis from the CheckMate 025 study.

Tomita Y, Fukasawa S, Shinohara N, Kitamura H, Oya M, Eto M, Tanabe K, Kimura G, Yonese J, Yao M, Motzer RJ, Uemura H, McHenry MB, Berghorn E, Ozono S.

Jpn J Clin Oncol. 2017 Jul 1;47(7):639-646. doi: 10.1093/jjco/hyx049.

21.

Drug therapy for renal cell carcinoma in the elderly.

Miyake H, Ozono S.

Nihon Rinsho. 2017 Apr;75(4):602-606. Japanese.

PMID:
30549865
22.

Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trial.

Oyama M, Sugiyama T, Nozawa M, Fujimoto K, Kishida T, Kimura G, Tokuda N, Hinotsu S, Shimozuma K, Akaza H, Ozono S.

Jpn J Clin Oncol. 2017 Jun 1;47(6):551-559. doi: 10.1093/jjco/hyw194.

23.

Efficacy and safety of a 3-month dosing regimen of degarelix in Japanese patients with prostate cancer: a phase II maintenance-dose-finding study.

Ozono S, Tsukamoto T, Naito S, Ohashi Y, Ueda T, Nishiyama T, Maeda H, Kusuoka H, Akazawa R, Ito M, Akaza H.

Jpn J Clin Oncol. 2017 May 1;47(5):438-446. doi: 10.1093/jjco/hyx011.

24.
25.

Contralateral pneumothorax during retroperitoneal laparoscopic donor nephrectomy: A case report.

Matsushita Y, Miyake H, Motoyama D, Sugiyama T, Nagata M, Otsuka A, Furuse H, Ozono S.

Asian J Endosc Surg. 2017 May;10(2):202-204. doi: 10.1111/ases.12354. Epub 2017 Mar 17.

PMID:
28303679
26.

Factor X Deficiency with Heterozygous Mutations of Novel p.G435S and Known p.G244R in a Patient Presenting with Severe Umbilical Hemorrhage.

Matsuo Y, Mizuochi T, Miho M, Nakagawa S, Ozono S, Ueda K, Sogabe Y, Seki R, Soejima K, Okamura T, Yamashita Y.

Kurume Med J. 2017 Apr 13;63(1.2):23-28. doi: 10.2739/kurumemedj.MS6300007. Epub 2017 Mar 15.

27.

Functional analysis of fatty acid binding protein 7 and its effect on fatty acid of renal cell carcinoma cell lines.

Takaoka N, Takayama T, Ozono S.

BMC Cancer. 2017 Mar 14;17(1):192. doi: 10.1186/s12885-017-3184-x.

28.

[Evaluation of CT-Guided Percutaneous Needle Biopsy for Diagnosis of Renal Tumor].

Kato T, Sugiyama T, Matsushita Y, Suzuki T, Motoyama D, Matsumoto R, Otsuka A, Furuse H, Tsukui H, Ushio T, Nasu H, Ozono S.

Hinyokika Kiyo. 2017 Feb;63(2):51-56. doi: 10.14989/ActaUrolJap_63_2_51. Japanese.

29.
30.

Four-dimensional phase-contrast vastly undersampled isotropic projection reconstruction (4D PC-VIPR) MR evaluation of the renal arteries in transplant recipients: Preliminary results.

Motoyama D, Ishii Y, Takehara Y, Sugiyama M, Yang W, Nasu H, Ushio T, Hirose Y, Ohishi N, Wakayama T, Kabasawa H, Johnson K, Wieben O, Sakahara H, Ozono S.

J Magn Reson Imaging. 2017 Aug;46(2):595-603. doi: 10.1002/jmri.25607. Epub 2017 Feb 2.

PMID:
28152259
31.

[Strangulation of the Penis by Four Metallic Washers].

Matsushita Y, Furuse H, Matsumoto R, Sugiyama T, Nagata M, Otsuka A, Ozono S.

Hinyokika Kiyo. 2016 Dec;62(12):661-665. doi: 10.14989/ActaUrolJap_62_12_661. Review. Japanese.

32.

Comparative Assessment of Efficacies Between 2 Alternative Therapeutic Sequences With Novel Androgen Receptor-Axis-Targeted Agents in Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer.

Miyake H, Hara T, Tamura K, Sugiyama T, Furuse H, Ozono S, Fujisawa M.

Clin Genitourin Cancer. 2017 Aug;15(4):e591-e597. doi: 10.1016/j.clgc.2016.12.015. Epub 2016 Dec 22.

PMID:
28063845
33.

Systematic regional lymph node dissection for upper tract urothelial carcinoma improves patient survival.

Furuse H, Matsushita Y, Yajima T, Kato T, Suzuki T, Matsumoto R, Motoyama D, Sugiyama T, Otsuka A, Ozono S.

Jpn J Clin Oncol. 2017 Mar 1;47(3):239-246. doi: 10.1093/jjco/hyw179.

PMID:
27920099
34.

The Effects of Unilateral Nephrectomy on Blood Pressure and Its Circadian Rhythm.

Ohashi N, Isobe S, Ishigaki S, Suzuki T, Motoyama D, Sugiyama T, Nagata M, Kato A, Ozono S, Yasuda H.

Intern Med. 2016;55(23):3427-3433. Epub 2016 Dec 1.

36.

Intrarenal renin-angiotensin system activity is augmented after initiation of dialysis.

Ohashi N, Isobe S, Ishigaki S, Suzuki T, Ono M, Fujikura T, Tsuji T, Kato A, Ozono S, Yasuda H.

Hypertens Res. 2017 Apr;40(4):364-370. doi: 10.1038/hr.2016.143. Epub 2016 Oct 20.

PMID:
27761002
37.

CYP2A13 Genetic Polymorphisms in Relation to the Risk of Bladder Cancer in Japanese Smokers.

Kumondai M, Hosono H, Orikasa K, Arai Y, Arai T, Sugimura H, Ozono S, Sugiyama T, Takayama T, Sasaki T, Hirasawa N, Hiratsuka M.

Biol Pharm Bull. 2016;39(10):1683-1686.

38.

Asia prostate cancer study (A-CaP Study) launch symposium.

Akaza H, Hirao Y, Kim CS, Oya M, Ozono S, Ye D, Cooperberg M, Hinotsu S, Lee JY, Zhu G, Namiki M, Horie S, Chung BH, Chen CH, Fai NC, Hakim L, Chiong E, Letran J, Umbas R, Suzuki K, Nishimura K, Ong TA, Lojanapiwat B, Wu TL, Kim WJ, Murphy D, Ogawa O, Carroll P, Naito S, Tsukamoto T.

Prostate Int. 2016 Sep;4(3):88-96. doi: 10.1016/j.prnil.2016.03.001. Epub 2016 Mar 10.

39.

Comparison of mirabegron and imidafenacin for efficacy and safety in Japanese female patients with overactive bladder: A randomized controlled trial (COMFORT study).

Otsuka A, Kageyama S, Suzuki T, Matsumoto R, Nagae H, Kitagawa M, Furuse H, Ozono S.

Int J Urol. 2016 Dec;23(12):1016-1023. doi: 10.1111/iju.13231. Epub 2016 Sep 29.

40.

Critical Diamond-Blackfan anemia due to ribosomal protein S19 missense mutation.

Ozono S, Mitsuo M, Noguchi M, Nakagawa S, Ueda K, Inada H, Ohga S, Ito E.

Pediatr Int. 2016 Sep;58(9):930-3. doi: 10.1111/ped.13018. Epub 2016 Sep 6.

PMID:
27601194
41.

Key predictive factors for efficacy of axitinib in first-line metastatic renal cell carcinoma: subgroup analysis in Japanese patients from a randomized, double-blind phase II study.

Tomita Y, Fukasawa S, Oya M, Uemura H, Shinohara N, Habuchi T, Rini BI, Chen Y, Bair AH, Ozono S, Naito S, Akaza H.

Jpn J Clin Oncol. 2016 Aug 29. [Epub ahead of print]

42.

Effect of Patient Education for Diabetic Outpatients by a Hospital Pharmacist: A Retrospective Study.

Ichiki Y, Kobayashi D, Kubota T, Ozono S, Murakami A, Yamakawa Y, Zeki K, Shimazoe T.

Yakugaku Zasshi. 2016 Dec 1;136(12):1667-1674. Epub 2016 Aug 29.

43.
44.

Assessment of Efficacy, Safety, and Quality of Life of 124 Patients Treated With Axitinib as Second-Line Therapy for Metastatic Renal-Cell Carcinoma: Experience in Real-World Clinical Practice in Japan.

Miyake H, Harada KI, Ozono S, Fujisawa M.

Clin Genitourin Cancer. 2017 Feb;15(1):122-128. doi: 10.1016/j.clgc.2016.06.019. Epub 2016 Jul 5.

PMID:
27473522
45.

Efficacy and safety of axitinib in elderly patients with metastatic renal cell carcinoma.

Miyake H, Harada K, Ozono S, Fujisawa M.

Med Oncol. 2016 Aug;33(8):95. doi: 10.1007/s12032-016-0813-1. Epub 2016 Jul 21.

PMID:
27444960
46.

Comparative Assessment of Clinical Outcomes Between Abiraterone Acetate and Enzalutamide in Patients With Docetaxel-Naive Metastatic Castration-Resistant Prostate Cancer: Experience in Real-World Clinical Practice in Japan.

Miyake H, Hara T, Terakawa T, Ozono S, Fujisawa M.

Clin Genitourin Cancer. 2017 Apr;15(2):313-319. doi: 10.1016/j.clgc.2016.06.010. Epub 2016 Jun 23.

PMID:
27424256
47.

The Relation between Hepatotoxicity and the Total Coumarin Intake from Traditional Japanese Medicines Containing Cinnamon Bark.

Iwata N, Kainuma M, Kobayashi D, Kubota T, Sugawara N, Uchida A, Ozono S, Yamamuro Y, Furusyo N, Ueda K, Tahara E, Shimazoe T.

Front Pharmacol. 2016 Jun 20;7:174. doi: 10.3389/fphar.2016.00174. eCollection 2016.

48.

[Progress of the treatment for CRPC].

Ozono S, Furuse H.

Nihon Rinsho. 2016 May 20;74 Suppl 3:615-8. Japanese. No abstract available.

PMID:
27344804
49.

[Prognostic factors in patients with castration-resistant prostate cancer].

Furuse H, Ozono S.

Nihon Rinsho. 2016 May 20;74 Suppl 3:171-5. Japanese. No abstract available.

PMID:
27344724
50.

Reduced expression of the DNA glycosylase gene MUTYH is associated with an increased number of somatic mutations via a reduction in the DNA repair capacity in prostate adenocarcinoma.

Shinmura K, Kato H, Kawanishi Y, Yoshimura K, Igarashi H, Goto M, Tao H, Inoue Y, Sugiyama T, Furuse H, Ozono S, Sugimura H.

Mol Carcinog. 2017 Feb;56(2):781-788. doi: 10.1002/mc.22509. Epub 2016 Jun 10.

PMID:
27253753

Supplemental Content

Support Center